Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(6)
Published: June 1, 2023
Abstract
Accumulating
evidence
shows
that
SARS‐CoV‐2
can
potentially
trigger
autoimmune
processes,
which
be
responsible
for
the
long‐term
consequences
of
COVID‐19.
Therefore,
this
paper
aims
to
review
autoantibodies
reported
in
COVID‐19
convalescents.
Six
main
groups
were
distinguished:
(i)
against
components
immune
system,
(ii)
cardiovascular
(iii)
thyroid
autoantibodies,
(iv)
specific
rheumatoid
diseases,
(v)
antibodies
G‐protein
coupled
receptors,
and
(vi)
other
autoantibodies.
The
reviewed
here
clearly
highlights
infection
may
induce
humoral
responses.
However,
available
studies
share
number
limitations,
such
as:
(1)
sole
presence
does
not
necessarily
implicate
clinically‐relevant
risks,
(2)
functional
investigations
rarely
performed
it
is
often
unknown
whether
observed
are
pathogenic,
(3)
control
seroprevalence,
healthy,
noninfected
individuals
was
reported;
thus
sometimes
detected
result
or
accidental
post‐COVID‐19
detection,
(4)
correlated
with
symptoms
syndrome,
(5)
size
studied
small,
(6)
focused
predominantly
on
adult
populations,
(7)
age‐
sex‐related
differences
seroprevalence
explored,
(8)
genetic
predispositions
involved
generation
during
infections
investigated,
(9)
reactions
following
variants
vary
clinical
course
remain
unexplored.
Further
longitudinal
advocated
assess
link
between
identified
particular
outcomes
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: March 30, 2023
Abstract
Several
millions
of
individuals
are
estimated
to
develop
post-acute
sequelae
SARS-CoV-2
condition
(PASC)
that
persists
for
months
after
infection.
Here
we
evaluate
the
immune
response
in
convalescent
with
PASC
compared
asymptomatic
and
uninfected
participants,
six
following
their
COVID-19
diagnosis.
Both
cases
characterised
by
higher
CD8
+
T
cell
percentages,
however,
proportion
blood
cells
expressing
mucosal
homing
receptor
β7
is
low
patients.
show
increased
expression
PD-1,
perforin
granzyme
B
PASC,
plasma
levels
type
I
III
(mucosal)
interferons
elevated.
The
humoral
characterized
IgA
against
N
S
viral
proteins,
particularly
those
who
had
severe
acute
disease.
Our
results
also
consistently
elevated
IL-6,
IL-8/CXCL8
IP-10/CXCL10
during
disease
increase
risk
PASC.
In
summary,
our
study
indicates
defined
persisting
immunological
dysfunction
as
late
infection,
including
alterations
parameters,
redistribution
β7Integrin
IgA,
indicative
potential
persistence
involvement
etiopathology
Angiogenesis,
Journal Year:
2023,
Volume and Issue:
26(4), P. 547 - 563
Published: July 28, 2023
Post-COVID-19
syndrome
(PCS)
is
a
lingering
disease
with
ongoing
symptoms
such
as
fatigue
and
cognitive
impairment
resulting
in
high
impact
on
the
daily
life
of
patients.
Understanding
pathophysiology
PCS
public
health
priority,
it
still
poses
diagnostic
treatment
challenge
for
physicians.In
this
prospective
observational
cohort
study,
we
analyzed
retinal
microcirculation
using
Retinal
Vessel
Analysis
(RVA)
patients
compared
to
an
age-
gender-matched
healthy
(n
=
41,
matched
out
n
204).PCS
exhibit
persistent
endothelial
dysfunction
(ED),
indicated
by
significantly
lower
venular
flicker-induced
dilation
(vFID;
3.42%
±
1.77%
vs.
4.64%
2.59%;
p
0.02),
narrower
central
artery
equivalent
(CRAE;
178.1
[167.5-190.2]
189.1
[179.4-197.2],
0.01)
arteriolar-venular
ratio
(AVR;
(0.84
[0.8-0.9]
0.88
[0.8-0.9],
0.007).
When
combining
AVR
vFID,
predicted
scores
reached
good
ability
discriminate
groups
(area
under
curve:
0.75).
Higher
severity
correlated
(R
-
0.37
0.017).
The
association
microvascular
changes
were
amplified
exhibiting
higher
levels
inflammatory
parameters.Our
results
demonstrate
that
prolonged
hallmark
PCS,
impairments
seem
explain
As
potential
therapies
emerge,
RVA
parameters
may
become
relevant
clinical
biomarkers
diagnosis
therapy
management.This
study
was
previously
registered
at
ClinicalTrials
("All
Eyes
PCS-Analysis
Microvasculature
Patients
Syndrome".
NCT05635552.
https://clinicaltrials.gov/ct2/show/NCT05635552
).
Persistent
post-COVID-19
syndrome.
Acute
SARS-CoV-2
infection
indirectly
or
directly
causes
endotheliitis
N
41
recruited
vessel
analysis
performed
assess
function.
Images
SVA
DVA
are
illustrative
data
analysis.
For
each
patient
cohort,
diameter
three
measurement
cycles
calculated
plotted
diameter-time
curve.
exhibited
reduced
veins
(vFID)
measured
dynamic
(DVA)
arteriolar
(CRAE)
(AVR)
tendency
towards
(CRVE)
when
naïve
participants.
Created
BioRender.com.
Molecular Psychiatry,
Journal Year:
2023,
Volume and Issue:
28(7), P. 2872 - 2877
Published: May 2, 2023
Abstract
In
the
aftermath
of
COVID-19
pandemic,
we
are
witnessing
an
unprecedented
wave
post-infectious
complications.
Most
prominently,
millions
patients
with
Long-Covid
complain
about
chronic
fatigue
and
severe
post-exertional
malaise.
Therapeutic
apheresis
has
been
suggested
as
efficient
treatment
option
for
alleviating
mitigating
symptoms
in
this
desperate
group
patients.
However,
little
is
known
mechanisms
biomarkers
correlating
outcomes.
Here,
have
analyzed
different
cohorts
specific
before
after
therapeutic
apheresis.
that
reported
a
significant
improvement
following
two
cycles
apheresis,
there
was
reduction
neurotransmitter
autoantibodies,
lipids,
inflammatory
markers.
Furthermore,
observed
70%
fibrinogen,
erythrocyte
rouleaux
formation
fibrin
fibers
largely
disappeared
demonstrated
by
dark
field
microscopy.
This
first
study
demonstrating
pattern
clinical
patient
group.
It
may
therefore
form
basis
more
objective
monitoring
score
other
postinfectious
syndromes.
Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(6)
Published: June 1, 2023
Abstract
Accumulating
evidence
shows
that
SARS‐CoV‐2
can
potentially
trigger
autoimmune
processes,
which
be
responsible
for
the
long‐term
consequences
of
COVID‐19.
Therefore,
this
paper
aims
to
review
autoantibodies
reported
in
COVID‐19
convalescents.
Six
main
groups
were
distinguished:
(i)
against
components
immune
system,
(ii)
cardiovascular
(iii)
thyroid
autoantibodies,
(iv)
specific
rheumatoid
diseases,
(v)
antibodies
G‐protein
coupled
receptors,
and
(vi)
other
autoantibodies.
The
reviewed
here
clearly
highlights
infection
may
induce
humoral
responses.
However,
available
studies
share
number
limitations,
such
as:
(1)
sole
presence
does
not
necessarily
implicate
clinically‐relevant
risks,
(2)
functional
investigations
rarely
performed
it
is
often
unknown
whether
observed
are
pathogenic,
(3)
control
seroprevalence,
healthy,
noninfected
individuals
was
reported;
thus
sometimes
detected
result
or
accidental
post‐COVID‐19
detection,
(4)
correlated
with
symptoms
syndrome,
(5)
size
studied
small,
(6)
focused
predominantly
on
adult
populations,
(7)
age‐
sex‐related
differences
seroprevalence
explored,
(8)
genetic
predispositions
involved
generation
during
infections
investigated,
(9)
reactions
following
variants
vary
clinical
course
remain
unexplored.
Further
longitudinal
advocated
assess
link
between
identified
particular
outcomes